Skip to main content
logo
Sernova Biotherapeutics Inc (TSX:SVA)
Canada flag Canada · Delayed Price · Currency is CAD
0.1100
-0.0100 (-8.33%)
Jul 24, 2026, 3:53 PM EST

Sernova Biotherapeutics Financials Overview

Millions CAD. Fiscal year is Nov - Oct.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Operating Income
-10.31-15.02-31.66-40.5-24.75-6.94
Net Income
-11.83-15.74-32.19-39-24.42-6.97
Earnings Per Share
0.040.050.100.130.090.03
EPS Growth
-33.33%-50.00%-23.08%44.44%200.00%0%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash & Investments
1.050.276.0119.8149.7827.87
Total Debt
2.454.770.570.140.280.39
Net Cash (Debt)
-1.4-4.515.4419.6749.527.48
Net Cash Growth
---72.33%-60.26%80.13%746.40%
Net Cash Per Share
-0.00-0.010.020.060.180.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Operating Cash Flow
-5.5-10.91-18.9-30.34-14.42-6.84
Capital Expenditures
----0.1-0.33-0.02
Free Cash Flow
-5.5-10.91-18.9-30.44-14.75-6.86
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
PE Ratio
-3.002.505.858.8941.67